Amylyx Pharmaceuticals Inc (AMLX)
Healthcare
Drug Manufacturers - Specialty & Generic
20.30 $
-2.1%
vs. previous close
Closing price · As of: 31. Jul 2026
Amylyx Pharmaceuticals Inc (AMLX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q1 26), "Operating Cash Flow" came in at -37 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 8.6 | -5.2 | 14 | -0.5 | -67 | -42 | -59 | -40 | -25 | -30 | -28 | -37 | -120 | |
| 0.3 | 0.3 | 0.3 | 0.3 | 0.2 | 0.2 | 0.2 | 0.2 | 0.1 | 0.1 | 0.1 | 0.1 | 0.5 | |
| 10.0 | 10 | 9.5 | 9.9 | 9.6 | 6.8 | 6.7 | 6.8 | 7.4 | 7.1 | 6.4 | 6.1 | 27 | |
| 8.0 | – | – | – | – | – | – | – | – | – | – | – | – | |
| -22 | -34 | 1.6 | 0.2 | -8.7 | -11 | -27 | -9.2 | 10.0 | -1.9 | 0.1 | -5.3 | 2.9 | |
| 0.3 | 0.4 | 0.4 | 0.1 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.0 | 0.1 | |
| 123 | -108 | 21 | 0.8 | -29 | 39 | 65 | -44 | 23 | 5.2 | 29 | 36 | 94 | |
| -0.7 | -0.1 | -0.1 | -1.3 | 0.0 | 1.3 | – | -0.9 | – | – | – | – | – | |
| 1.4 | 0.9 | 0.2 | 0.1 | 0.0 | 0.1 | 0.1 | 66 | 0.0 | 192 | -0.2 | 3.2 | 195 | |
| 133 | -113 | 35 | 0.4 | -96 | -2.4 | 5.6 | -18 | -1.7 | 167 | 1.5 | 2.5 | 169 | |
| 8.3 | -5.5 | 13 | -0.6 | -67 | -42 | -59 | -40 | -25 | -30 | -28 | -37 | -121 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.